�������ýҕ�l

In the global race to make a coronavirus vaccine, a state-owned Chinese company is boasting that its employees, including top executives, received experimental shots even before the government approved testing in people. “Giving a helping hand in forging the sword of victory,” reads an online post from SinoPharm with pictures of workers it says helped “pre-test” its vaccine. (McNeil and Neergaard, 7/16)

Chinese state-owned pharmaceutical company Sinopharm has begun Phase III clinical trials of a COVID-19 vaccine in the emirate of Abu Dhabi using around 15,000 volunteers, the Abu Dhabi government media office said on Thursday. The human trial taking place in Abu Dhabi, part of the United Arab Emirates, is a partnership between Sinopharm’s China National Biotec Group (CNBG), Abu Dhabi based artificial intelligence and cloud computing company Group 42 and the Abu Dhabi Department of Health. (Barrington and Cornwell, 7/16)

The leading U.S. expert on infectious diseases, Dr. Anthony Fauci, predicted on Wednesday the country will meet its goal of a coronavirus vaccine by year’s end and was unmoved by the prospect that China would get there first. While there are no guarantees, “I feel good about the projected timetable,” Fauci told Reuters in an interview. His comments follow promising early stage data for the Moderna Inc’s coronavirus vaccine, released on Tuesday, that was developed by scientists at the National Institute of Allergy and Infectious Diseases, which Fauci directs. (Steenhuysen, 7/15)

China has approved an early-stage trial in humans of German firm BioNTech’s experimental COVID-19 vaccine, its local partner Shanghai Fosun Pharmaceutical said on Thursday. The potential vaccine is one of the two most advanced candidates that BioNTech is working on with its partner Pfizer Inc and they received “fast track” status this week from the U.S. Food and Drug Administration which is designed to speed up the regulatory review process. (7/15)